Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8652)
All Articles published online
|
Publishing Process of This Article
|
Jun 21, 2015 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Antonuzzo L, Giommoni E, Pastorelli D, Latiano T, Pavese I, Azzarello D, Aieta M, Pastina I, Di Fabio F, Bertolini A, Corsi DC, Mogavero S, Angelini V, Pazzagli M, Di Costanzo F. Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study. World J Gastroenterol 2015; 21(23): 7281-7288 [PMID: 26109816 DOI: 10.3748/wjg.v21.i23.7281] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i23/7281.htm |
| Number | Citing Articles |
| 1 |
Federica Cosso, Daniele Lavacchi, Sara Fancelli, Enrico Caliman, Marco Brugia, Gemma Rossi, Costanza Winchler, Serena Pillozzi, Lorenzo Antonuzzo. Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer. Anti-Cancer Drugs 2023; 34(3): 451 doi: 10.1097/CAD.0000000000001410
|
| 2 |
Nuttavut Sumransub, Kornpong Vantanasiri, Ajay Prakash, Emil Lou. Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?. Molecular Therapy - Oncolytics 2021; 22: 1 doi: 10.1016/j.omto.2021.05.001
|
| 3 |
Prabha Singh, Pramita Waghambare, Tabassum Asif Khan, Abdelwahab Omri. Colorectal cancer management: strategies in drug delivery. Expert Opinion on Drug Delivery 2022; 19(6): 653 doi: 10.1080/17425247.2022.2084531
|
| 4 |
Tehnia Naz, Anees ur Rehman, Aleena Shahzad, Muhammad Fawad Rasool, Zikria Saleem, Rabia Hussain. Impact of bevacizumab on clinical outcomes and its comparison with standard chemotherapy in metastatic colorectal cancer patients: a systematic review and meta-analysis. Journal of Pharmaceutical Policy and Practice 2024; 17(1) doi: 10.1080/20523211.2024.2354300
|
| 5 |
Toshikazu Moriwaki, Masahiko Gosho, Akinori Sugaya, Takeshi Yamada, Yoshiyuki Yamamoto, Ichinosuke Hyodo. Optimal Maintenance Strategy for First-Line Oxaliplatin-Containing Therapy with or without Bevacizumab in Patients with Metastatic Colorectal Cancer: A Meta-Analysis. Cancer Research and Treatment 2021; 53(3): 703 doi: 10.4143/crt.2020.805
|
| 6 |
Yaping Chen, Xiao Zheng, Changping Wu. The Role of the Tumor Microenvironment and Treatment Strategies in Colorectal Cancer. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.792691
|